FBL and non-small cell lung carcinoma: Furthermore, AFR, a ratio of serum Alb to plasma Fib, could amplify the sensitivity of inflammation and nutrition status in NSCLC patients and it was superior to the single Alb and Fib to predict survival of NSCLC.